RecruitingNot ApplicableNCT06721065

A Study of Language Interpretation Solutions for People With Breast Cancer

RSMI HEALS (Health Equity Advances Through Language Solutions) (AI)

Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

700 participants

Start Date

Dec 2, 2024

Study Type

INTERVENTIONAL

Conditions

Breast Cancer Breast Cancer Stage II Breast Cancer Stage III

Summary

The study will be conducted in 2 overlapping phases. In Phase 1, there will be a 3-arm randomized controlled trial of Remote Simultaneous Medical Interpreting/RSMI (Arm 1), versus Remote Consecutive Medical Interpreting/RCMI (Arm 2) and versus Remote Consecutive Video Medical Interpreting/RCVI (Arm 3) in breast cancer outpatient clinical encounters with Spanish- and Mandarin-speaking patients with Limited English Proficiency/LEP (Stages II and III disease) and English- speaking providers (who do not speak Spanish/Mandarin). In Phase 2, there will be a sequential mixed-methods explanatory, multi-stakeholder process evaluation to gather implementation potential data.

Eligibility

Min Age: 18 Years

Inclusion Criteria13

Phase I Patients
Age \>=18 years (per EMR)
Preferred language for healthcare is Spanish or Mandarin (per self-report)
Limited English Proficient; cannot speak English "very well" (per self-report)
Diagnosis of breast cancer or gastrointestinal (per EMR)
Will be visiting MSK oncology teams for the first or second appointment (per EMR)
Agrees to be audio-recorded (per self-report)
Phase 1 Providers
Breast or gastrointestinal cancer provider who sees patients (e.g., breast or gastrointestinal oncologists, advanced practice providers, and/or nurses)
Does not speak Spanish and/or Mandarin; providers who speak one language and not the other may participate (e.g., speaks Spanish but not Mandarin) (per self-report)
Agrees to be audio-record (per self-report) Phase 2 (clinic staff only; patient participants will be drawn from Phase 1)
Is a staff member who works/worked in one of the study clinic sites during the period of Phase 1 RCT study activities
Agrees to be audio-recorded (per self-report)

Exclusion Criteria7

Phase 1 Patients
Has significant psychiatric disturbance (i.e., acute psychiatric symptoms) sufficient to preclude completion of the assessments, interviews, or informed consent (per EMR, patient's care team, or study team)
Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection (per EMR, patients, care team, or study team)
Phase I Providers
None
Phase 2 (clinic staff only; Phase 1 patient participants follow above criteria)
None

Interventions

OTHERRemote Simultaneous Medical Interpreting/RSMI

Remote Simultaneous Medical Interpreting (RSMI), "UN-style" simultaneous interpreting applied to the medical encounter, which holds tremendous promise for closely approximating a same language encounter, decreasing interpreting errors, and improving outcomes.

OTHERRemote Consecutive Medical Interpreting/RCMI

Remote Consecutive Medical Interpreting (RCMI; "audio consecutive"), is the most commonly utilized remote interpreting

OTHERRemote Consecutive Video Medical Interpreting/RCVI

Remote Simultaneous Medical Interpreting (RSMI), "UN-style" simultaneous interpreting applied to the medical encounter